Healthcare
Healthcare Providers
Payers dwarf hospitals and labs
UnitedHealth $447.6 billion and CVS $402.1 billion also appear on Insurance. HCA $75.6 billion is the hospital operator. Labcorp $14.0 billion and DaVita $13.6 billion sit above Quest $11.0 billion. Do not read the first two bars as hospital revenue.
UnitedHealth: do not add the bars
2025 UnitedHealthcare $344.9 billion and Optum $270.6 billion include affiliated revenue. Eliminations were $168.0 billion. Consolidated $447.6 billion. CMS premiums were 44 percent of consolidated revenue.
HCA is a managed-care hospital
2025: managed care and other insurers $37.0 billion (48.9 percent). Medicare plus Managed Medicare $24.7 billion. Medicaid plus Managed Medicaid $9.6 billion. Admissions 2.30 million.
HCA volume is admissions, not implants
2025: 2.30 million admissions, 4.11 million equivalent admissions, $18,407 revenue per equivalent admission. Group revenue $75.6 billion. These are hospital operating statistics.
| Metric | Value | Note |
|---|---|---|
| Admissions | 2,297,065 | Inpatient |
| Equivalent admissions | 4,107,152 | Inpatient plus outpatient acuity |
| Revenue per equivalent admission | $18,407 | As reported |
| Revenue | $75.600B | Calendar 2025 |
CVS is three piles before eliminations
2025 segment revenues: Health Services $190.4 billion, Health Care Benefits $143.4 billion, Pharmacy and Consumer Wellness $139.4 billion. Consolidated $402.1 billion after intersegment eliminations. Do not add the bars.
Labcorp is a clinical lab with a CRO sidecar
2025: Diagnostics Laboratories $10.88 billion, Biopharma Laboratory Services $3.10 billion. Group $13.95 billion. Diagnostics is the patient-testing book. Biopharma is central labs and early development.
DaVita is US dialysis
2025: US dialysis $11.79 billion, international $1.35 billion, integrated kidney care $542 million. Consolidated $13.64 billion after eliminations. Do not add the bars. Dialysis is not hospital admissions.
DaVita volume is treatments, not admissions
2025: 28.73 million US dialysis treatments. Average revenue per treatment $409.56. Group revenue $13.64 billion. These are dialysis statistics, not HCA admissions and not medtech implant units.
| Metric | Value | Note |
|---|---|---|
| US dialysis treatments | 28,733,980 | Full year 2025 |
| Revenue per treatment | $409.56 | Average patient service |
| Consolidated revenue | $13.643B | Group, not treatments |